CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 

Wright Current Income Fund - 25th anniversary

 
 
 
 
 
 
Zeria Pharmaceutical Co Ltd Company Snapshot
Zeria Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zeria Pharmaceutical Co Ltd with three other companies in this sector in Japan: Towa Pharmaceutical Company Limited (2014 sales of 61.35 billion Japanese Yen [US$579.15 million] of which 100% was ), Torii Pharmaceutical Co., Ltd. (58.11 billion Japanese Yen [US$548.55 million] of which 100% was ), and Fuso Pharmaceutical Industries Ltd (49.10 billion Japanese Yen [US$463.49 million] ).

Sales Analysis. Zeria Pharmaceutical Co Ltd reported sales of ¥62.00 billion (US$585.25 million) for the fiscal year ending March of 2014. This represents an increase of 16.3% versus 2013, when the company's sales were ¥53.32 billion. This was the third consecutive year of growth at Zeria Pharmaceutical Co Ltd. Sales of Consumer Healthcare Business saw an increase of 19.9% in 2014, from ¥21.18 billion to ¥25.39 billion. Not all segments of Zeria Pharmaceutical Co Ltd experienced an increase in sales in 2014: sales of Other fell 18.7% to ¥176.70 million. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zeria Pharmaceutical Co Ltd
  Stock Performance Chart for Zeria Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/17/2014): 2,025.00
(Figures in Japanese Yen)
1 Week -8.3%   13 Weeks -17.0%  
4 Weeks -18.7%   52 Weeks -12.5%  
 
Zeria Pharmaceutical Co Ltd Key Data:
  Ticker: 4559 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2014 Sales 61,996,830,000
(Year Ending Jan 2015).
Employees: 1,322
  Currency: Japanese Yen Market Cap: 107,560,519,650
  Fiscal Yr Ends: March Shares Outstanding: 53,116,306
  Share Type: Common Closely Held Shares: 11,442,700
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.